Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.41 USD | +0.74% | -0.73% | -10.87% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 18 | Amneal Pharmaceuticals Announces Launch of Pemetrexed Injection, 100mg/10 Mg/10 Mg/50 Mg/Ll | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.87% | 1.67B | |
+27.92% | 672B | |
+27.00% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.26% | 217B | |
+5.75% | 199B | |
-8.59% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals : Guggenheim Adjusts Amneal Pharmaceuticals' Price Target to $8 From $6.50, Maintains Buy Rating